Skeletal Dysplasia Account Manager (Central Region)

Key Responsibilities:

• Develop and execute a dynamic territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet and exceed sales goals.
• Demonstrate deep expertise in Infigratinib, achondroplasia, and the broader skeletal dysplasia landscape; engage HCPs in clinically relevant, compliant discussions.
• Use sales and target data to identify growth opportunities and address territory challenges proactively.

What You Will Do:

• The Skeletal Dysplasia Account Manager is a high-impact, community-focused role central to BridgeBio’s commercial success.
• This individual will drive the launch of Infigratinib—a first-in-class therapy for achondroplasia—bring deep clinical acumen, urgency, and a passion for partnering with providers and families.
• They will develop and execute a dynamic territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams.

Who You Are:

• 8–10 years in pharmaceutical or biotech; 4+ years in rare disease, genetic disease, or skeletal dysplasia required.
• Achondroplasia or pediatric rare disease experience highly preferred; BS/BA required, MBA a plus; willingness to travel extensively.
• Product/indication launch experience: Proven record of accomplishment launching products into competitive or new markets, including creating demand through disease-state and stakeholder education.